Antimalarial Activity of Molecules Interfering with Plasmodium falciparum Phospholipid Metabolism. Structure−Activity Relationship Analysis-Reference-Cited by-同舟云学术

Antimalarial Activity of Molecules Interfering with Plasmodium falciparum Phospholipid Metabolism. Structure−Activity Relationship Analysis

Published:1997-10-01 Issue:22 Volume:40 Page:3557-3566
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Calas Michèle¹,Cordina Gérard¹,Bompart Jacques¹,Ben Bari Mohamed¹,Jei Taïb¹,Ancelin Marie L.¹,Vial Henri¹

Affiliation:

1. Laboratoire des Aminoacides, Peptides et Proteines, CNRS, UMR 5810, and CNRS, UMR 5539, CP 107, Université de Montpellier II, Place E. Bataillon, 34095 Montpellier Cedex 5, France, Laboratoire de Chimie Organique Pharmaceutique, Faculté de Pharmacie, Université de Montpellier I, 15, Avenue C. Flahault, 34060 Montpellier Cedex, France, and Département de Chimie, Faculté des Sciences Ben M'Sik, Casablanca, Maroc

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm9701886

Reference18 articles.

1. The dynamics of drug resistance in Plasmodium falciparum

2. Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemo‐proteomics in antimalarial target identification and engagement;Medicinal Research Reviews;2023-05-26

2. Selective Synthesis of Bisdimethylamine Derivatives from Diols and an Aqueous Solution of Dimethylamine through Iridium‐Catalyzed Borrowing Hydrogen Pathway;ChemCatChem;2021-12-08

3. Crystal Structure of the Apo and the ADP-Bound Form of Choline Kinase from Plasmodium falciparum;Crystals;2020-07-14

4. In Silico Investigation of First-Pass Effect on Selected Small Molecule Excipients and Structural Dynamics of P-glycoprotein;Bioinformatics and Biology Insights;2020-01

5. Miscellaneous agents of clinical interest;Antimalarial Agents;2020